| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Gilliam Joseph E, PRESIDENT & COO
Received 44,917 shares by exercise or conversion ($2.41M) · Sold 44,917 shares ($11.1M) |
| 16 Nov 2026 |
Form 4: Gilliam Joseph E, PRESIDENT & COO
Gave up 986 shares to cover exercise price or tax ($86.4K) |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | 144 |
| 06 Nov 2026 |
8-K: Regulation FD Disclosure
Disclaimer All statements other than statements of historical facts included in this presentation that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking s... |
| 05 Nov 2026 |
Form 4: Kliman Gilbert H, Director
Received 2,500 shares by exercise or conversion ($64.4K) · Sold 2,500 shares ($633K) |
| 04 Nov 2026 | 144 |
| 03 Nov 2026 |
Form 4: Weisner Aimee S, Director
Gave 2,382 shares as a gift · Acquired 2,382 shares (Gift) |
| 03 Nov 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Received 12,969 shares by exercise or conversion ($985K) · Sold 44,436 shares ($10.6M) |
| 03 Nov 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Gave up 755 shares to cover exercise price or tax ($67.6K) |
| 30 Oct 2026 | 144 |
| 28 Oct 2026 | 10-Q |
| 28 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
This document is intended to be read by investors in advance of regularly scheduled quarterly conference calls and was designed to provide a review of Glaukos Corporation’s recent financial and operational performance and general busines... |
| 07 Oct 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Sold 1,527 shares ($251K) |
| 05 Oct 2026 | 144 |
| 28 Sep 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Sold 1,615 shares ($249K) |
| 25 Sep 2026 | 144 |
| 18 Sep 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Sold 1,457 shares ($243K) |
| 16 Sep 2026 | 144 |
| 01 Sep 2026 |
Form 4: Navratil Tomas, CHIEF DEVELOPMENT OFFICER
Sold 13,744 shares ($2.48M) |
Loading...